BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1964793)

  • 1. Induction of plasminogen activator inhibitor type 2 expression during differentiation of human K562 cells towards a macrophage phenotype.
    Rehemtulla A; Arndt A; Hart DA
    Biochem Cell Biol; 1990 Dec; 68(12):1337-43. PubMed ID: 1964793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation-linked expression of the plasminogen activator inhibitor type-2 gene in the human HL-60 promyelocytic cell line.
    Arndt AD; Gohill J; Rankin K; Houwen B; Hart DA
    Exp Cell Res; 1989 Dec; 185(2):473-81. PubMed ID: 2513217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells.
    Antalis TM; Dickinson JL
    Eur J Biochem; 1992 Apr; 205(1):203-9. PubMed ID: 1555580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line.
    Niiya K; Takeuchi T; Kobayashi M; Miyoshi I; Hayashi T; Sakuragawa N
    Thromb Haemost; 1991 Aug; 66(2):232-8. PubMed ID: 1771617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
    Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C; Kruithof EK; Schleuning WD
    J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.
    Bosma PJ; Kooistra T
    J Biol Chem; 1991 Sep; 266(27):17845-9. PubMed ID: 1655729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
    Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative regulation of a tumor necrosis factor response in melanoma cells.
    Johnson SE; Baglioni C
    J Biol Chem; 1990 Apr; 265(12):6642-9. PubMed ID: 2324095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.
    Zinzar S; Ohnuma T; Holland JF
    Leuk Res; 1989; 13(1):23-30. PubMed ID: 2915572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells.
    Hallbeck AL; Walz TM; Wasteson A
    Biosci Rep; 2001 Jun; 21(3):325-39. PubMed ID: 11892999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).
    Oliver LJ; Keeton M; Wilson EL
    Blood; 1989 Sep; 74(4):1321-7. PubMed ID: 2504306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the regulation of the plasminogen activator inhibitor-1 gene expression.
    Descheemaeker K
    Verh K Acad Geneeskd Belg; 1993; 55(3):225-64. PubMed ID: 8342330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line].
    Niiya K
    Rinsho Ketsueki; 1991 May; 32(5):490-6. PubMed ID: 1870266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
    Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
    Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.